Virios Therapeutics, Inc. (VIRI) Financials

VIRI Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2023 4.2 million 358548
Sept. 30, 2023 5.2 million 487144
June 30, 2023 5.2 million 520032
March 31, 2023 6.5 million 549290

VIRI Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -1.5 million 148306
Sept. 30, 2023 -960454 148305
June 30, 2023 -742414 161664
March 31, 2023 -1.7 million 161697

VIRI Net Income

No data available :(

VIRI Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 3.3 million - -
Sept. 30, 2023 4.8 million - -
June 30, 2023 4.6 million - -
March 31, 2023 5.3 million - -

VIRI Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 19.3 million
Sept. 30, 2023 19.1 million
June 30, 2023 18.4 million
March 31, 2023 18.3 million

VIRI Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 - 298320 839805 1
Sept. 30, 2023 - 374200 900089 -
June 30, 2023 - 557843 919374 -
March 31, 2023 - 497714 1.1 million -

VIRI Cost of Revenue

No data available :(

VIRI

Price: $0.16

52 week price:
0.14
1.04

Earnings Per Share: -0.23 USD

P/E Ratio: -2.54

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 306080

Market Capitalization: 4.7 million

Links: